Metraipolis › archive › dc_d7d63e52bbfb

iNOS is a key mediator of anti-PD-1 melanoma therapy response — Europe PMC PMID:42440610

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42440610
DOI: 10.3389/fimmu.2026.1837275
License (as archived): solo-consultazione
Archived: 2026-10-08T11:54:48.499Z
SHA-256 of the archived text: 7c8a795939419d8e01657539ba2e0a8c5a83109041427a2f871220718e41e8fa
Stable URL of this page: https://metraipolis.com/documento/dc_d7d63e52bbfb

How to cite

iNOS is a key mediator of anti-PD-1 melanoma therapy response — Europe PMC PMID:42440610 — Europe PMC (en), https://europepmc.org/article/MED/42440610 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7d63e52bbfb (Metraipolis archive dc_d7d63e52bbfb, sha256 7c8a795939419d8e01657539ba2e0a8c5a83109041427a2f871220718e41e8fa)

BibTeX

@misc{dcd7d63e52bbfb,
  title = {iNOS is a key mediator of anti-PD-1 melanoma therapy response — Europe PMC PMID:42440610},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42440610},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7d63e52bbfb; sha256 7c8a795939419d8e01657539ba2e0a8c5a83109041427a2f871220718e41e8fa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440610. Agents can read the archived copy with the MCP tool read_document.